Norelgestromin/ethinyl estradiol transdermal system
Taneepanichskul, S.
Journal of the Medical Association of Thailand 88(Suppl 2): S82-S84
2005
ISSN/ISBN: 0125-2208 PMID: 17722322 Document Number: 13747
The transdermal contraceptive patch is an innovative contraceptive technology. The failure rate is quite low and has high continuation rate. The side effects and complications are not different from other hormonal contraceptives. This contraceptive method should be an alternative birth control technique for women.
Document emailed within 1 workday
Related Documents
Dittrich, R.; Parker, L.; Rosen, J.B.; Shangold, G.; Creasy, G.W.; Fisher, A.C. 2002: Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study American Journal of Obstetrics and Gynecology 186(1): 15-20Dittrich, R.; Parker, L.; Rosen, J.B.; Shangold, G.; Creasy, G.W.; Fisher, A.C. 2002: Transdermal contraception: Evaluation of three transdermal norelgestromin/ethinyl estradiol doses in a randomized, multicenter, dose-response study American Journal of Obstetrics and Gynecology 186(1): 15-20
Creasy, G.W.; Fisher, A.C.; Hall, N.; Shangold, G.A. 2003: Transdermal contraceptive patch delivering norelgestromin and ethinyl estradiol. Effects on the lipid profile Journal of Reproductive Medicine 48(3): 179-186
Sriprasert, I.; Stanczyk, F.Z.; Archer, D.F. 2015: Ethinyl estradiol and levonorgestrel in a transdermal contraceptive delivery system Expert Opinion on PharmacoTherapy 16(12): 1901-1909
Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
DelConte, A.; Loffer, F.; Grubb, G.S. 1999: Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. a multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms) Contraception 59(3): 187-193
Alfaya, T.; Mur Gimeno, P.; Iglesias, A.M.; Ventura, P.ón. 2011: Allergic contact dermatitis caused by an ethinylestradiol-norelgestromin transdermal therapeutic system Contact Dermatitis 64(4): 242-244
Höchel, J.; Schuett, B.; Ludwig, M.; Zurth, C. 2014: Implications of different application sites on the bioavailability of a transdermal contraceptive patch containing ethinyl estradiol and gestodene: an open-label, randomized, crossover study International Journal of Clinical Pharmacology and Therapeutics 52(10): 856-866
Waellnitz, K.; Duijkers, I.; Klipping, C.; Rautenberg, T.; Rohde, B.; Zurth, C. 2016: A two-centre, open-label, randomised study of ovulation inhibition with three transdermal contraceptive patches, each containing different amounts of ethinyl estradiol and gestodene in healthy, young women Journal of Obstetrics and Gynaecology: the Journal of the Institute of Obstetrics and Gynaecology 36(1): 106-113
Kashanian, M.; Shahpourian, F.; Zare, O. 2010: A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran European Journal of Obstetrics Gynecology and Reproductive Biology 150(1): 47-51
Creinin, M.D.; Lippman, J.S.; Eder, S.E.; Godwin, A.J.; Olson, W. 2002: The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol Contraception 66(3): 147-152
Hofmann, B.; Reinecke, I.; Schuett, B.; Merz, M.; Zurth, C. 2014: Pharmacokinetic overview of ethinyl estradiol dose and bioavailability using two transdermal contraceptive systems and a standard combined oral contraceptive International Journal of Clinical Pharmacology and Therapeutics 52(12): 1059-1070
Gemzell-Danielsson, K.; Sitruk-Ware, R.; Creinin, M.D.; Thomas, M.; Barnhart, K.T.; Creasy, G.; Sussman, H.; Alami, M.; Burke, A.E.; Weisberg, E.; Fraser, I.; Miranda, M.-J.é; Gilliam, M.; Liu, J.; Carr, B.R.; Plagianos, M.; Roberts, K.; Blithe, D. 2019: Segesterone acetate/ethinyl estradiol 12-month contraceptive vaginal system safety evaluation Contraception 99(6): 323-328
Gelas, B.; Thébault, J.; Roux, I.; Herbrecht, F.; Zartarian, M. 1997: Comparative study of the acceptability of a new estradiol Tx 11323 (A) gel and a transdermal matrix system Contraception Fertilite Sexualite 25(6): 470-474
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
Grandi, G.; Piacenti, I.; Volpe, A.; Cagnacci, A. 2014: Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology 30(9): 676-680
Setnikar, I.; Rovati, L.C.; Thebault, J.J.; Guillaume, M.; Mignot, A.; Renoux, A.; Gualano, V. 1997: Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrix Arzneimittel-Forschung 47(7): 859-865
Gaussem, P.; Alhenc-Gelas, M.; Thomas, J.-L.; Bachelot-Loza, C.; Remones, V.; Ali, F.D.; Aiach, M.; Scarabin, P.-Y. 2011: Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. a double-blind, randomised study Thrombosis and Haemostasis 105(3): 560-567
Rungruxsirivorn, T.; Panyakamlerd, K.; Trerattanachart, S.; Taechakraichana, N. 2006: Randomized comparison of lower and standard dosages of transdermal estradiol on serum estradiol levels and vaginal maturation index Journal of the Medical Association of Thailand 89(9): 1362-1367
Ankarberg-Lindgren, C.; Elfving, M.; Wikland, K.A.; Norjavaara, E. 2001: Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls Journal of Clinical Endocrinology and Metabolism 86(7): 3039-3044